>>> LATEST NEWS...NEW FREE REPORT NOW AVAILABLE "The Forecast of Forecasting"...LATEST NEWS...NEW Speaker Confirmed - Bjarne Lemmich, Head of Sales Forecasting, Novartis... LATEST NEWS...NEW Speaker Confirmed - Gavin Heaney, Director International, Commercial Operations, Gilead Sciences...LATEST NEWS...NEW Speaker Confirmed - Martin Joseph, Head of Forecasting & Information Management, AstraZeneca... >>> LATEST NEWS...NEW FREE REPORT NOW AVAILABLE "The Forecast of Forecasting"...LATEST NEWS...NEW Speaker Confirmed - Bjarne Lemmich, Head of Sales Forecasting, Novartis... LATEST NEWS...NEW Speaker Confirmed - Gavin Heaney, Director International, Commercial Operations, Gilead Sciences...LATEST NEWS...NEW Speaker Confirmed - Martin Joseph, Head of Forecasting & Information Management, AstraZeneca...

2nd April - Morning & Afternoon Sessions

ADDED-VALUE- Pre-Summit Half-day Workshop - Morning Session

"New Product Forecasting in Pharma"

The inherent uncertainty of the business environment complicates planning and coordination of essential business functions. Understanding fundamental market drivers and their influence in shaping product demand is integral to good business planning and full utilization of company resources.

ZS Associates has developed customized forecasting tools and processes to serve our clients in more than 100 engagements, and now offers training sessions to provide our clients with the knowledge and tools to enhance their forecasting capabilities.

 

About the program

New product forecasting in Pharma is a half-day training program designed for Pharma executives with responsibility for developing forecasts. It will provide participants with the principles and tools essential for a good forecast. Individuals who work in market research, strategic planning, and product management are the key stakeholders in a forecast development process and will benefit from a comprehensive understanding of the process and their role in making a successful forecast.

New Product Forecasting:

  • Introduction and developing a disease model
  • Patient-based forecasting vs. trend-based forecasting
  • Forecasting approaches and product lifecycle
  • Tackling historical Rx reconciliation
  • Capturing market dynamics with patient flow modeling
  • Market environment (e.g. aging population, WHI, etc)
  • Competition
  • Product uptake and erosion curves, selection of analogs
  • Conversion from patients to revenue
  • How to use market research to support forecasts

Art Cook , Principal , ZS associates

ADDED-VALUE- Pre-Summit Half-day Workshop - Afternoon Session

"In-Market Forecasting in Pharma"

Strategic Forecasting Through the Life Cycle of In-Market Brands

In-Market forecasting in Pharma is a half-day training program designed for Pharma executives with responsibility for developing forecasts. It will provide participants with the principles and tools essential for a good forecast. Individuals who work in market research, strategic planning, and product management are the key stakeholders in a forecast development process and will benefit from a comprehensive understanding of the process and their role in making a successful forecast.

 

About the program:

FORECASTING THE IMPACT OF COMPETITION

Quantifying the impact of new competitor brands in your class
Quantifying the impact of completely new competitor categories (therapy classes)

FORECASTING THE IMPACT OF MARKETING ON YOUR BRAND
* Quantifying the promotional response function for your brand
* Understanding the relationship between the quantity and quality of marketing on sales

FORECASTING IN THE SHORT AND LONG TERM

* The dangers of relying on a mixture of extrapolation and judgment
* Why other approaches work much better under some circumstances

FORECASTING THE IMPACT OF NEW INDICATIONS

* How to forecast the eventual impact
* What if some brands in the category have the indication and others do not?

FORECASTING THE IMPACT OF MAJOR CLINICAL DEVELOPEMENTS

* What type of clinical studies move shares?
* How can we predict these movements?

FORECASTING LINE EXTENSIONS

* Understanding the difference between line extensions, brand extensions and new presentations
* How to analyse and predict them

FORECASTING THE IMPACT OF GENERICS
* What will be the impact and the speed of generic erosion?
* How and where will generics boost the sales of a molecule (therapeutic subsistution)?

Gary Johnson , Managing Director, Inpharmation

Overview
Who should attend?
Reasons to attend
Partners
Sponsor / Exhibit
Call for papers
Free Reports
Venue
Info Request
Programme
Certification Training
Register Now
Pre-Event Workshop

Global Sponsor:

Panel Sponsor:

Workshop Sponsors:

Official Partner:

Exhibitors: